MET and central nervous system cancer: Besides, upon the treatment of inhibitors for c-Met and mTOR (SU11274 and rapamycin), glioma cells (A172, U251, and U373) exhibited a similar effect as cells treated by LINC00998 (Supplementary Figs. S4 and S5).